Dear users,
Vechain (VEN) and SALT will be launched on Huobi Pro on December 18, 2017 (GMT+8). Deposits will be available from 14:00, December 18, 2017(GMT+8). Withdrawals will be available from 18:00, December 18, 2017 (GMT+8). VEN/BTC, VEN/ETH, SALT/BTC and SALT/ETH trading will be available at New Zone from 14:00, December 19, 2017 (GMT+8).
【5 Million RMB Rewards】
Round 1: Own VEN Get VEN!
During 2017/12/18 14:00 to 2017/12/31 14:00 (GMT+8)，verified users who deposit or trade no less than 500VEN during the promotion period and have 500VEN balances after the promotion will get 5VEN rewards. Rewards will be given in 3 work days.
Round 2: Trade One Get One Free!
During 2017/12/19 14:00 to 2017/12/20 14:00 (GMT+8), verified users with cumulative VEN trading volume will get the same amount of VEN rewards up to 10VEN. Rewards will be given in 3 work days.
Round 3: Trade VEN Get Porsche!
During 2017/12/19 14:00 to 2017/12/25 14:00 (GMT+8)，TOP50 traders (Buy amount plus Sell amount within 7 days after the market opening) can get the following rewards:
TOP1 Porsche Macan
TOP2-3 1BTC
TOP4-10 6666VEN
TOP11-20 500VEN
TOP21-50 200VEN
Ranking will be updated on this page every work day before 18:00. Final rewards will be given within 7 work days after the promotion.
*Above promotion is subject to Huobi Pro's final interpretative decision. Huobi Pro reserves the right to disqualify any person who is known or suspected by Huobi Pro to be cheating or violating any rules and regulations set by Huobi Pro.
What is Vechain (VEN)? Click here: https://www.huobipro.com/en-us/assetintro/#ven
What is SALT? Click here: https://www.huobipro.com/en-us/assetintro/#salt
Risk Reminder:
Investing in digital assets comes with high risks due to huge price fluctuations. Before investing, please have a full understanding of all the risks of investing in digital assets and be prudent of your own investment decisions.
Huobi.pro-Official (Telegram Group): https://t.me/huobiproofficial
Enjoy your trading on Huobi Pro!
Huobi Pro
December 18, 2017
Comments
0 comments
Article is closed for comments.